XML 42 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value

NOTE 13 - FAIR VALUE

Financial instruments measured at fair value on a recurring basis and their location within the accompanying consolidated financial statements are as follows:

 

 

December 31, 2024

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Location on Balance Sheet

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps - current portion

$

 

 

$

825

 

 

$

 

 

$

825

 

 

Prepaid expenses and other assets

Interest rate swaps - long-term portion

 

 

 

 

129

 

 

 

 

 

 

129

 

 

Other assets

Company-owned life insurance policies

 

 

 

 

23,174

 

 

 

 

 

 

23,174

 

 

Other assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest swaps - current portion

$

 

 

$

15

 

 

$

 

 

$

15

 

 

Accrued expenses and other current liabilities

Interest swaps - long-term portion

 

 

 

 

153

 

 

 

 

 

 

153

 

 

Other long-term liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Location on Balance Sheet

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps - current portion

$

 

 

$

4,820

 

 

$

 

 

$

4,820

 

 

Prepaid expenses and other assets

Foreign currency forward and swap contracts

 

 

 

 

6

 

 

 

 

 

 

6

 

 

Prepaid expenses and other assets

Interest rate swaps - long-term portion

 

 

 

 

398

 

 

 

 

 

 

398

 

 

Other assets

Company-owned life insurance policies

 

 

 

 

20,438

 

 

 

 

 

 

20,438

 

 

Other assets

Financial and non-financial instruments measured or remeasured at fair value on a non-recurring basis include certain impaired right-of-use assets from operating leases and assets acquired and liabilities assumed from acquisitions, using the discounted cash flows method with Level 3 inputs as of the impairment and acquisition dates.